VivoSeq
Other

Acupuncture

0

Pipeline Programs

5

Active Trials

2

Companies Involved

Acupuncture is an early-stage landscape with 0 programs across 2 companies. The most active players are Korean Pharmacoacupuncture Institute, Isabell Xiang Ge.

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

93/100

Attrition Rate

3/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

29

clinical trials

Completed13 · 45%
Unknown status10 · 34%
Recruiting4 · 14%
Withdrawn1 · 3%
Not yet recruiting1 · 3%

Trial Activity

29 trials

Low-frequency Electrical Stimulation of Acupuncture Points
Completed··Phase 1·NCT06061731·57 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)